Willow Lane Acquisition
We have no price for Willow Lane Acquisition since 18 May 2026. It may have been taken over, merged or renamed, so the figures below are from then.
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
We do not have this company's yearly figures yet, so its profit, growth, price and debt cannot be judged here.
Money in, money out
What Willow Lane Acquisition sold, what it kept, and what it did with the cash.
Sales went from $0 in 2024 to $0 in 2025, with $3.44 million of profit last year.
Willow Lane Acquisition vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Willow Lane Acquisition | No profit yet | ||
 Churchill Capital Corp X | No profit yet | ||
 Drugs Made In America Acquisition II | 155.8× · No profit yet | ||
 Bain Capital GSS Investment Cor | No profit yet | ||
 Cantor Equity Partners IV | 96.3× · No profit yet |
AI analysis
An AI analyst reads Willow Lane Acquisition's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2024 | 2025 |
|---|---|---|
| 0 | 0 | |
| – | – | |
| -0 | -2 | |
| -0 | -2 | |
| 0 | 3 | |
| – | – | |
| – | – | |
| – | – | |
| – | – |
Balance sheet
| In millions of USD | 2024 | 2025 |
|---|---|---|
| Total assets | 129 | 133 |
| Cash | 1 | 0 |
| Total debt | – | – |
| Total liabilities | 5 | 5 |
| 124 | 128 | |
| – | – | |
| -0.1% | -1.2% | |
| 0.1% | 2.7% |
Cash flow
| In millions of USD | 2024 | 2025 |
|---|---|---|
| -0 | -1 | |
| – | – | |
| -0 | -1 | |
| Dividends paid | – | – |
| – | – | |
| – | – |
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about Willow Lane Acquisition
Is Willow Lane Acquisition a good stock to buy?
We do not have this company's yearly figures yet, so its profit, growth, price and debt cannot be judged here. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Willow Lane Acquisition AI analysis
What does Willow Lane Acquisition do?
Willow Lane Acquisition Corp., identified by the symbol WLACU, operates as a Special Purpose Acquisition Company (SPAC). Its primary objective is to seek out and finalize a significant business combination with one or more existing enterprises. It is in Shell Companies.
Does Willow Lane Acquisition pay a dividend?
No. Willow Lane Acquisition does not pay a dividend at the moment.
Is Willow Lane Acquisition stock halal?
Questionable. Willow Lane Acquisition sits in a grey zone: scholars disagree about its industry. How we check
Who are Willow Lane Acquisition's competitors?
The largest listed companies in the same industry are Churchill Capital Corp X, Drugs Made In America Acquisition II, Bain Capital GSS Investment Cor and Cantor Equity Partners IV. The peers table on this page compares their profit, growth and price with Willow Lane Acquisition's.
Prices: daily closes to May 18, 2026. Fundamentals: company reports via invest-like data.